Qual é o preço para ViewRay, Inc. (VRAY)

O preço para ViewRay, Inc. (VRAY) é $0.014

Qual é a capitalização de mercado para ViewRay, Inc. (VRAY)

A capitalização de mercado para ViewRay, Inc. (VRAY) é $2.07M

Histórico de Preços de ViewRay, Inc. (VRAY)

ViewRay, Inc. specializes in the development, production, and global distribution of advanced radiation therapy systems that leverage magnetic resonance imaging (MRI). These integrated systems are utilized to both image and deliver treatment for cancer patients in various countries, including the United States, France, Taiwan, and the United Kingdom. The company's key product, MRIdian, is an MRI-guided radiation therapy solution engineered to address critical concerns during treatment, such as beam distortion and potential skin toxicity. ViewRay's client base spans a diverse range of medical facilities, including university research and teaching hospitals, local community hospitals, private medical practices, government institutions, and independent cancer treatment centers. MRIdian systems are sold to these clients via ViewRay's direct sales force and through its established distribution channels. The company was founded in 2004 and operates out of its main office in Oakwood, Ohio.

Ano	Desempenho
2023	-99.70%
2022	-13.86%
2021	33.62%
2020	-7.02%
2019	-28.31%
2018	-34.19%
2017	168.70%
2016	-29.83%
2015	0.00%

Ano

Desempenho

2023

-99.70%

2022

-13.86%

2021

33.62%

2020

-7.02%

2019

-28.31%

2018

-34.19%

2017

168.70%

2016

-29.83%

2015

0.00%

Empresa	Preço da ação	Variação 1a%	País
Abbott Laboratories ABT.US	$111.15	-15.64%	US
Stryker Corporation SYK.US	$339.00	-11.24%	US
Medtronic plc MDT.US	$91.19	-1.97%	IE
Boston Scientific Corporation BSX.US	$51.77	-49.83%	US
Edwards Lifesciences Corporation EW.US	$91.49	16.90%	US

Empresa

Preço da ação

Variação 1a%

País